Association between prophylactic angiotensin-converting enzyme inhibitors and overall survival in Duchenne muscular dystrophy—analysis of registry data

French registry study (n=576,390) found prophylactic angiotensin-converting enzyme inhibitors treatment was associated with a lower risk of death (HR 0.39; 95% CI 0.17–0.92) and hospitalisation for heart failure (HR 0.16; 95%CI 0.04–0.62) in pts with Duchenne muscular dystrophy.

European Heart Journal